US-based biotech Moderna Therapeutics has appointed Israel Ruiz to its board of directors to serve as audit committee chair.
Ruiz is currently executive vice president, treasurer and chief financial officer at Massachusetts Institute of Technology (MIT), where he is responsible for leading all of the institute’s administrative and financial operations.
Before taking on his current role in 2011, Ruiz held a number of leadership positions at MIT, including vice president of finance, and lead the institute’s digital learning technologies drive.
Ruiz also serves as audit committee chair on Fortive’s board of directors, an industrial growth technology specialist.
Dr Noubar Afeyan, co-founder and chairman of Moderna Therapeutics, said: “We are delighted to welcome Israel to Moderna’s board of directors.
“His progressive leadership at MIT has helped ensure the continued, unparalleled contributions of the institute on a regional, national and global scale, through education, innovation and entrepreneurship.
“We look forward to leveraging Israel’s insights as Moderna evolves into a leading, clinical stage biotechnology company by harnessing the promise of messenger RNA science to improve lives.”